These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6660656)

  • 1. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrodermatitis enteropathica-like syndrome secondary to isoleucine deficiency during treatment of maple syrup urine disease.
    Giacoia GP; Berry GT
    Am J Dis Child; 1993 Sep; 147(9):954-6. PubMed ID: 8362810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency in inborn errors of metabolism.
    Oztürk Y
    Pediatr Dermatol; 2008; 25(3):415. PubMed ID: 18577070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrodermatitis dysmetabolica in an infant with maple syrup urine disease.
    Flores K; Chikowski R; Morrell DS
    Clin Exp Dermatol; 2016 Aug; 41(6):651-4. PubMed ID: 27334242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoleucine Deficiency in a Neonate Treated for Maple Syrup Urine Disease Masquerading as Acrodermatitis Enteropathica.
    Ross B; Kumar M; Srinivasan H; Ekbote AV
    Indian Pediatr; 2016 Aug; 53(8):738-40. PubMed ID: 27567652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
    Lie IE; Haugstad S; Holm H
    Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iatrogenic acrodermatitis enteropathica-like syndrome in leucinosis].
    Puzenat E; Durbise E; Fromentin C; Humbert P; Aubin F
    Ann Dermatol Venereol; 2004; 131(8-9):801-4. PubMed ID: 15505548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal deepithelialization caused by acute deficiency of isoleucine during treatment of a patient with maple syrup urine disease.
    Tornqvist K; Tornqvist H
    Acta Ophthalmol Scand Suppl; 1996; (219):48-9. PubMed ID: 8741119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
    Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
    Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
    [No Abstract]   [Full Text] [Related]  

  • 18. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary treatment of maple sirup urine disease (branched-chain ketoaciduria).
    Noel MB; Stanley PB; Girz JC; Allen RJ
    J Am Diet Assoc; 1976 Jul; 69(1):62-8. PubMed ID: 932376
    [No Abstract]   [Full Text] [Related]  

  • 20. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.